G. Loriga

发表

Synthesis of Tricyclic Condensed Rings Incorporating the Pyrazole or Isoxazole Moieties Bonded to a 4-Piperidinyl Substituent

G. Pinna, G. Chelucci, Giansalvo Pinna, 2013, Molecules.

Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone‐Based Cannabinoid Receptor Type 2 Ligands

S. Merighi, S. Gessi, P. Morales, 2018, ChemMedChem.

Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives

D. Schuster, V. Temml, S. Piras, 2021, Molecules.

Pyridinyl- and pyridazinyl-3,6-diazabicyclo[3.1.1]heptane-anilines: Novel selective ligands with subnanomolar affinity for α4β2 nACh receptors.

M. Sciaccaluga, C. Gotti, F. Deligia, 2018, European journal of medicinal chemistry.

Novel diazabicycloalkane delta opioid agonists.

G. Pinna, P. Lazzari, M. Falzoi, 2015, Bioorganic & medicinal chemistry.

Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazole: a versatile architecture for CB2 selective ligands.

G. Pinna, P. Lazzari, M. Falzoi, 2014, European journal of medicinal chemistry.

3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[3.1.1]heptanes as novel potent dopamine uptake inhibitors.

G. Murineddu, G. Pinna, S. Ruiu, 2007, Bioorganic & medicinal chemistry.

Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for the opioid receptors.

S. Villa, L. Toma, S. Gessi, 2006, Bioorganic & medicinal chemistry.

Tricyclic pyrazoles. Part 2: Synthesis and biological evaluation of novel 4,5-dihydro-1H-benzo[g]indazole-based ligands for cannabinoid receptors.

P. Lazzari, G. Grella, G. Murineddu, 2005, Bioorganic & medicinal chemistry.

Synthesis of novel diazatricyclodecanes (DTDs). Effects of structural variation at the C3' allyl end and at the phenyl ring of the cinnamyl chain on mu-receptor affinity and opioid antinociception.

S. Villa, G. Grella, G. Cossu, 2003, Bioorganic & medicinal chemistry.

N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes as mu-opioid receptor agonists. Effects on mu-affinity of arylalkenyl chain modifications.

W. Fratta, G. Murineddu, G. Pinna, 2002, Bioorganic & medicinal chemistry.

Novel pyrazole derivatives as neutral CB₁ antagonists with significant activity towards food intake.

A. Volonterio, Francesca Olimpieri, M. Zanda, 2013, European journal of medicinal chemistry.

Chemistry, biological properties and SAR analysis of quinoxalinones.

S. Piras, A. Carta, G. Loriga, 2006, Mini reviews in medicinal chemistry.

Synthesis and in vitro evaluation of the anti-viral activity of N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides.

M. Ferrone, M. Fermeglia, S. Pricl, 2006, Medicinal chemistry (Shariqah (United Arab Emirates)).

Synthesis and cytotoxic activities of pyrrole[2,3-d]pyridazin-4-one derivatives.

G. Murineddu, G. Pinna, G. Chelucci, 2002, Chemical & pharmaceutical bulletin.

Tricyclic pyrazoles. Part 1: synthesis and biological evaluation of novel 1,4-dihydroindeno[1,2-c]pyrazol-based ligands for CB1and CB2 cannabinoid receptors.

Giovanni Loriga, Gabriele Murineddu, G. Murineddu, 2003, Bioorganic & medicinal chemistry.

Synthesis and anti-HIV-1 activity of new delavirdine analogues carrying arylpyrrole moieties.

P. la Colla, G. Grella, P. Colla, 2001, Chemical & pharmaceutical bulletin.

Binaphthalene-templated N,S- and N,P-heterobidentate ligands with an achiral oxazoline pendant: Synthesis and assessment in asymmetric catalysis

S. Medici, Rossana Taras, S. Gladiali, 2003 .

Synthesis and application in asymmetric copper(I)-catalyzed allylic oxidation of a new chiral 1,10-phenanthroline derived from pinene

Giorgio Chelucci, Giovanni Loriga, Gabriele Murineddu, 2002 .

Design of a new class of chiral C2-symmetric dipyridylmethane ligands and their application in asymmetric catalysis

G. Murineddu, G. Pinna, G. Chelucci, 2002 .

Chromophore-modified bis-benzo[g]indole carboxamides: synthesis and antiproliferative activity of bis-benzo[g]indazole-3-carboxamides and related dimers.

G. Grella, G. Murineddu, G. Pinna, 2003, Farmaco.

Synthesis and biological evaluation of novel delta (δ) opioid receptor ligands with diazatricyclodecane skeletons.

P. Lazzari, G. Murineddu, G. Pinna, 2013, European journal of medicinal chemistry.

Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide.

L. Toma, P. Lazzari, G. Murineddu, 2005, Journal of medicinal chemistry.

Synthesis of Chiral C2-Symmetric 1,10-Phenantroline from Occuring Monoterpenes

G. Murineddu, G. Chelucci, G. Loriga, 2003 .

Differential modulation of GABA(A) receptor function by aryl pyrazoles.

G. Biggio, M. P. Mascia, E. Maciocco, 2014, European journal of pharmacology.

Design, synthesis and biological evaluation of 1,5-disubstituted α-amino tetrazole derivatives as non-covalent inflammasome-caspase-1 complex inhibitors with potential application against immune and inflammatory disorders

P. Spanu, M. Fuggetta, F. Ulgheri, 2021, European Journal of Medicinal Chemistry.

Novel pyrrolocycloalkylpyrazole analogues as CB1 ligands

P. Fossa, E. Cichero, P. Lazzari, 2018, Chemical biology & drug design.

Synthesis and analgesic‐antiinflammatory activities of novel acylarylhydrazones with a 5‐phenyl‐4‐R‐3‐pyrrolyl‐acyl moiety

E. Gavini, G. Murineddu, G. Pinna, 2001, Archiv der Pharmazie.

Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2',4'-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide.

P. Lazzari, M. Falzoi, A. Sanna, 2006, Journal of medicinal chemistry.

Novel thienocycloalkylpyridazinones as useful scaffolds for acetylcholinesterase inhibition and serotonin 5-HT6 receptor interaction.

J. Brea, P. Fossa, E. Cichero, 2023, Bioorganic & medicinal chemistry.

Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists.

P. Fossa, E. Cichero, J. Fernández-Ruiz, 2018, Bioorganic & medicinal chemistry.